Miguel Viveiros
Overview
Explore the profile of Miguel Viveiros including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
190
Citations
4102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patil M, Munteanu T, Brasseur G, Ferreira C, Costa S, Couto I, et al.
Adv Healthc Mater
. 2025 Mar;
:e2404145.
PMID: 40066601
Efflux-mediated antibiotic resistance poses a significant global threat, affecting diverse bacterial species. Clinicians recognize the danger of efflux mechanisms during antibiotic treatment, yet precise diagnostic tools remain unavailable. The antibiogram...
2.
Andrade M, Neves J, Bento M, Marques J, Seabra S, Silveira H, et al.
Antibiotics (Basel)
. 2025 Feb;
14(2).
PMID: 40001426
Antimicrobial-resistant is a growing threat to human health for which alternative therapeutic options are needed. In this study, we aimed to evaluate the efficacy of amlodipine (AML) and imipramine (IMI)...
3.
Elias R, Modesto A, Machado D, Pereira B, Phelan J, Melo-Cristino J, et al.
Med Microbiol Immunol
. 2025 Jan;
214(1):6.
PMID: 39775075
\nKlebsiella pneumoniae is a common pathogen of healthcare-associated infections expressing a plethora of antimicrobial resistance loci, including ADP-ribosyltransferase coding genes (arr), able to mediate rifampicin resistance. The latter has activity...
4.
Malaquias T, Ribeiro E, Dutra T, Ricardo M, Salvato R, Bhering M, et al.
Rev Soc Bras Med Trop
. 2024 Sep;
57:e004162024.
PMID: 39292021
Background: Few studies in routine settings have confirmed the high accuracy of the Xpert MTB/RIF assay for detecting rifampicin resistance (RR) and the first-line probe assay (FL-LPA) for detecting both...
5.
Ferrinho P, Viveiros M, Fronteira I
One Health
. 2023 Mar;
16:100512.
PMID: 36875890
•Multidimensionality of AMR determination argues in favour of considering it a glocal syndemic.•Lack of attention to syndemic nature of AMR limits the effectiveness of measures taken so far.•The syndemic approach...
6.
Froberg G, Maurer F, Chryssanthou E, Fernstrom L, Benmansour H, Boarbi S, et al.
Clin Microbiol Infect
. 2023 Feb;
29(6):758-764.
PMID: 36813087
Objective: For non-tuberculous mycobacteria (NTM), minimum inhibitory concentration (MIC) distributions of wild-type isolates have not been systematically evaluated despite their importance for establishing antimicrobial susceptibility testing (AST) breakpoints. Methods: We...
7.
Ferreira C, Abrantes P, Costa S, Viveiros M, Couto I
Int J Mol Sci
. 2022 Dec;
23(23).
PMID: 36499632
NorA is one of the main native MDR efflux pumps of , contributing to reduced susceptibility towards fluoroquinolones and biocides, but little is known about its variability within or its...
8.
Marques J, de Faria C, Reis M, Machado D, Santos S, Santos M, et al.
Front Pharmacol
. 2022 May;
13:868545.
PMID: 35600870
The upsurge of multidrug-resistant tuberculosis has toughened the challenge to put an end to this epidemic by 2030. In 2020 the number of deaths attributed to tuberculosis increased as compared...
9.
Armada A, Gomes B, Viveiros M, Rueff J, Rodrigues A
Cancer Drug Resist
. 2022 May;
2(3):897-911.
PMID: 35582584
ABCB1 is a major player in cancer drug resistance. The purpose of this study was to functionally assess the regulation of ABCB1 activity in a doxorubicin-resistant breast cancer cell line...
10.
Rodrigues L, Bento Cunha R, Vassilevskaia T, Viveiros M, Cunha C
Molecules
. 2022 May;
27(9).
PMID: 35566073
In December 2019, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19) was first identified in the province of Wuhan, China. Since...